Swiss National Bank’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-116,200
| Closed | -$465K | – | 2493 |
|
|
2019
Q4 | $465K | Buy |
116,200
+5,400
| +5% | +$25.4K | ﹤0.01% | 2437 |
|
|
2019
Q3 | $543K | Hold |
110,800
| – | – | ﹤0.01% | 2337 |
|
|
2019
Q2 | $675K | Buy |
110,800
+18,700
| +20% | +$99.4K | ﹤0.01% | 2312 |
|
|
2019
Q1 | $535K | Hold |
92,100
| – | – | ﹤0.01% | 2354 |
|
|
2018
Q4 | $1.24M | Buy |
92,100
+1,900
| +2% | +$32K | ﹤0.01% | 1872 |
|
|
2018
Q3 | $1.75M | Hold |
90,200
| – | – | ﹤0.01% | 1807 |
|
|
2018
Q2 | $2.31M | Buy |
90,200
+6,800
| +8% | +$159K | ﹤0.01% | 1617 |
|
|
2018
Q1 | $1.68M | Buy |
83,400
+5,500
| +7% | +$128K | ﹤0.01% | 1756 |
|
|
2017
Q4 | $1.56M | Hold |
77,900
| – | – | ﹤0.01% | 1788 |
|
|
2017
Q3 | $1.61M | Hold |
77,900
| – | – | ﹤0.01% | 1768 |
|
|
2017
Q2 | $1.15M | Buy |
77,900
+13,500
| +21% | +$225K | ﹤0.01% | 1960 |
|
|
2017
Q1 | $1.03M | Hold |
64,400
| – | – | ﹤0.01% | 2011 |
|
|
2016
Q4 | $811K | Hold |
64,400
| – | – | ﹤0.01% | 2163 |
|
|
2016
Q3 | $1.8M | Hold |
64,400
| – | – | ﹤0.01% | 1575 |
|
|
2016
Q2 | $2.25M | Hold |
64,400
| – | – | ﹤0.01% | 1424 |
|
|
2016
Q1 | $1.7M | Buy |
64,400
+16,800
| +35% | +$495K | ﹤0.01% | 1541 |
|
|
2015
Q4 | $1.63M | Hold |
47,600
| – | – | ﹤0.01% | 1477 |
|
|
2015
Q3 | $1.37M | Buy |
47,600
+9,100
| +24% | +$389K | ﹤0.01% | 1568 |
|
|
2015
Q2 | $1.72M | Buy |
+38,500
| New | +$1.45M | ﹤0.01% | 1414 |
|
Other funds holding DPLO
Swiss National Bank's DPLO Position: Q1 2020 in Review
Swiss National Bank sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 116,200 shares — an estimated $465K sold.
Swiss National Bank first reported a position in DPLO in Q2 2015 and held it in 19 quarters. The position peaked at $2.31M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Swiss National Bank reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Swiss National Bank sold 116,200 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $465K.
- Swiss National Bank first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 19 quarters.
- Swiss National Bank's DIPLOMAT PHARMACY, INC. position peaked at $2.31M in Q2 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.